Skip to Main Content

In biopharma, patents are everything. In tech? Not so much.

Which is why it was unusual to see a company that’s trying to turn software into medicine announce this week that it’s bagged several patents.


Boston-based Akili Interactive Labs’s new patents, issued in the U.S. and Japan, are meant to deter competitors from copying the algorithms underlying the video games it’s developing to try to treat conditions like ADHD, depression, and multiple sclerosis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!